Get the Stockscreener App
26.83
0.89%
-0.25
Overview
News
Price History
Option Chain
Why FMS Down?
Discussions
Forecast
Stock Split
Dividend History
Fresenius Medical Care Ag Adr stock is traded at $26.83, with a volume of 597.19K.
It is down -0.89% in the last 24 hours and down -6.74% over the past month.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three quarters of sales while the balance is generated from medical technology products that enable dialysis treatments.
See More
Previous Close:
$27.08
Open:
$26.24
24h Volume:
597.19K
Relative Volume:
1.40
Market Cap:
$16.81B
Revenue:
$20.92B
Net Income/Loss:
$666.06M
P/E Ratio:
23.49
EPS:
1.1422
Net Cash Flow:
$1.85B
1W Performance:
-5.46%
1M Performance:
-6.74%
6M Performance:
+16.49%
1Y Performance:
+36.59%
1-Day Range:
$26.16
$26.90
1-Week Range:
$26.16
$29.07
52-Week Range:
$17.93
$30.46
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
Name
Fresenius Medical Care Ag Adr
Sector
Industry
Phone
-
Address
-
Compare FMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FMS
Fresenius Medical Care Ag Adr
|
26.82 | 16.81B | 20.92B | 666.06M | 1.85B | 1.1422 |
|
HCA
Hca Healthcare Inc
|
378.75 | 87.79B | 71.59B | 5.78B | 4.95B | 22.49 |
|
THC
Tenet Healthcare Corp
|
169.13 | 14.54B | 20.52B | 1.46B | 1.41B | 15.12 |
|
EHC
Encompass Health Corp
|
120.31 | 12.02B | 5.51B | 494.70M | 386.40M | 4.84 |
|
UHS
Universal Health Services Inc
|
171.96 | 11.13B | 16.08B | 1.20B | 1.06B | 17.82 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-06-24 | Initiated | Berenberg | Buy |
| Jan-08-24 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Nov-24-23 | Upgrade | HSBC Securities | Reduce → Hold |
| Nov-17-23 | Upgrade | Societe Generale | Hold → Buy |
| Aug-14-23 | Downgrade | UBS | Buy → Neutral |
| Aug-01-23 | Resumed | Citigroup | Neutral |
| Jul-12-23 | Initiated | Goldman | Buy |
| Mar-07-23 | Initiated | Bernstein | Mkt Perform |
| Jan-03-23 | Downgrade | Jefferies | Buy → Underperform |
| Oct-26-22 | Downgrade | Deutsche Bank | Hold → Sell |
| Oct-18-22 | Initiated | Morgan Stanley | Equal-Weight |
| Oct-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-27-22 | Upgrade | Jefferies | Underperform → Buy |
| Feb-11-22 | Downgrade | Jefferies | Hold → Underperform |
| Nov-23-21 | Initiated | HSBC Securities | Hold |
| Nov-11-21 | Upgrade | Jefferies | Underperform → Hold |
| Feb-04-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-03-21 | Downgrade | Deutsche Bank | Buy → Hold |
| Aug-05-20 | Downgrade | Jefferies | Buy → Hold |
| May-20-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-21-20 | Upgrade | Jefferies | Hold → Buy |
| Jun-20-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-10-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-26-18 | Upgrade | UBS | Neutral → Buy |
| Aug-28-18 | Upgrade | HSBC Securities | Hold → Buy |
| Jul-05-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Jan-04-18 | Upgrade | UBS | Sell → Neutral |
| Dec-11-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-01-16 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-06-16 | Upgrade | Citigroup | Neutral → Buy |
| Jul-08-16 | Upgrade | Jefferies | Underperform → Hold |
| Jan-04-16 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-04-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Sep-03-15 | Upgrade | Goldman | Neutral → Buy |
| Aug-13-15 | Downgrade | Societe Generale | Buy → Hold |
| Jul-31-15 | Reiterated | RBC Capital Mkts | Sector Perform |
| Aug-02-13 | Reiterated | Feltl & Co. | Hold |
| Jan-14-13 | Upgrade | HSBC Securities | Neutral → Overweight |
View All
Fresenius Medical Care Ag Adr Stock (FMS) Latest News
Fresenius Medical Care price target raised to €56 on medium-term outlook - Investing.com
Bernstein raises Fresenius Medical Care price target on restructuring progress - Investing.com India
Fresenius Medical Care's Narrow Moat Reinforced by Margin Expansion Plans - Morningstar
Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation - freseniusmedicalcare.com
5 Stocks To Ride The German Market RallyCureVac (NASDAQ:CVAC), BioNTech (NASDAQ:BNTX) - Benzinga
Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S. - Fresenius Medical Care
New research and innovation for kidney care at European Renal Association Congress 2025 - Fresenius Medical Care
ApolloDialDb™: A Dialysis Database of the Future - freseniusmedicalcare.com
61st ERA Congress - freseniusmedicalcare.com
Fresenius Medical Care sets record with dividend hike By Investing.com - Investing.com India
Fresenius Medical Care sets record with dividend hike - Investing.com
Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History - Fresenius Medical Care
Fresenius Medical Care ADR earnings beat by $0.07, revenue topped estimates - Investing.com
Fresenius Medical Care starts 2025 with strong organic revenue and income growth - freseniusmedicalcare.com
Fresenius Medical Care Celebrates 40 of Dialysis Center in Sokolov, Czech Republic - Fresenius Medical Care
Fresenius Medical Care AG completes EUR 1.1 billion bond issue By Investing.com - Investing.com India
Fresenius Medical Care AG completes EUR 1.1 billion bond issue - Investing.com
Kidney transplantation and value-based care - freseniusmedicalcare.com
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence - Benzinga
Why Fresenius Medical Care Stock Might Be A Great Pick - Barchart.com
From Kidney Failure to Fresenius Medical Care Employee: A Transplant Story - Fresenius Medical Care
Dialysis Nurse Becomes Kidney Patient After COVID-19 - Fresenius Medical Care
What Sets Our Nurses Apart - freseniusmedicalcare.com
A Transplant Story: Patient Care Technician Gives Dialysis Patient the Gift of Life - freseniusmedicalcare.com
Fresenius Medical Care plans bond sale stabilization By Investing.com - Investing.com South Africa
The Zacks Analyst Blog Highlights Reddit, Ubiquiti And Fresenius Medical Care AG - Barchart.com
Fresenius Medical Care plans bond sale stabilization - Investing.com
Predicting Population Trends in Kidney Health Using Advanced Mathematical Modeling - Fresenius Medical Care
Dry Bicarbonate Concentrate Bags for Hemodialysis in the State of São Paulo in Brazil - Fresenius Medical Care
Fresenius Economic Profit Margins Should Rise Along With Improvement in Both Operating Segments - Morningstar
Fresenius Medical Care publishes its joint Annual Report and Sustainability Statement for 2024: Building the Momentum - Fresenius Medical Care
Kidney Disease: Evolving the Standard of Care - Fresenius Medical Care
Sanctuary Advisors LLC Acquires New Holdings in Fresenius Medical Care AG (NYSE:FMS) - MarketBeat
Fresenius Medical Care ADR earnings missed by $0.26, revenue fell short of estimates - Investing.com South Africa
Fresenius Medical Care published form 20-F for the fiscal year 2024 - Fresenius Medical Care
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
Earnings call transcript: Fresenius Medical Care sees strong Q4 2024 growth - Investing.com
Fresenius Medical Care Q4 earnings miss estimates, stock edges higher - Investing.com
Dialysis firm FMC beats profit estimates in fourth quarter By Reuters - Investing.com
Annual Press Conference 2025 - freseniusmedicalcare.com
Fresenius Medical Care delivers 18% earnings growth in 2024 and continues the acceleration momentum into 2025 - Fresenius Medical Care
Fresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics - Fresenius Medical Care
Growing Stronger Together: Embracing Diversity - Fresenius Medical Care
Corporate Citizenship - freseniusmedicalcare.com
Fresenius Medical Care: A 'Buy' Going Into 2025 (NYSE:FMS) - Seeking Alpha
Virtual reality as the next step in patient empowerment - freseniusmedicalcare.com
Coming Back Home: Dr. Len Usvyat Appointed as the Next Head of the Renal Research Institute - Fresenius Medical Care
17,962 miles halfway around the world - Fresenius Medical Care
“How can we improve and speed up medical decisions?” - Fresenius Medical Care
20 years creating a future worth living - freseniusmedicalcare.com
Overcoming challenges and seizing opportunities - Fresenius Medical Care
Fresenius Medical Care Ag Adr Stock (FMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.05%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):